CSJ117

Exacerbation: CSJ117

Main objective:

In this study, an investigational medicine is inhaled at regular intervals over 12 months in order to determine if it can reduce the frequency of COPD flare-ups (exacerbations).

Who are we looking for?

  • Established diagnosis of COPD
  • Age: 40+
  • 2+ flare-ups that required steroid treatment/antibiotics
  • No prior history of asthma
  • Additional criteria not listed here

What’s provided for duration of study:

  • Study medication
  • Rescue medication
  • Safety tests
  • Modest payments for each visit completed
CONTACT US

If you would like additional information, please send us an email or give us a call!

334-504-7020
volunteerinfo@secclinicalresearch.com

Thank you for your interest – we look forward to hearing from you!

Facebook

© 2023 SEC CLINICAL RESEARCH - ALL RIGHTS RESERVED